Plantarc Bio Ltd (TA:PLNT) — Market Cap & Net Worth
Market Cap & Net Worth: Plantarc Bio Ltd (PLNT)
Plantarc Bio Ltd (TA:PLNT) has a market capitalization of $1.96 Million (ILA731.02 Million) as of September 7, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30082 globally and #439 in its home market, demonstrating a 1.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Plantarc Bio Ltd's stock price ILA220.90 by its total outstanding shares 3309259 (3.31 Million). Also see Plantarc Bio Ltd assets under control for a full breakdown of the balance sheet.
Plantarc Bio Ltd Market Cap History: 2021 to 2025
Plantarc Bio Ltd's market capitalization history from 2021 to 2025. Data shows change from $6.67 Million to $1.96 Million (-33.36% CAGR). Also see Plantarc Bio Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Plantarc Bio Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Plantarc Bio Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check PLNT live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.63x
Plantarc Bio Ltd's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $7.02 Million | $100.00K | -$4.98 Million | 70.24x | N/A |
| 2023 | $2.99 Million | $4.78 Million | -$2.11 Million | 0.63x | N/A |
| 2024 | $2.79 Million | $4.40 Million | -$2.57 Million | 0.63x | N/A |
Competitor Companies of PLNT by Market Capitalization
Companies near Plantarc Bio Ltd in the global market cap rankings as of September 7, 2026. Review how tangible is Plantarc Bio Ltd's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Plantarc Bio Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #320 globally with a market cap of $83.19 Billion USD.
- CSL Ltd (AU:CSL): Ranked #460 globally with a market cap of $59.90 Billion USD ( AU$84.66 Billion AUD).
- Argen-X (BR:ARGX): Ranked #576 globally with a market cap of $47.46 Billion USD ( €40.60 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $546.12 |
| #320 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $83.19 Billion | $827.72 |
| #460 | CSL Ltd | AU:CSL | $59.90 Billion | AU$174.50 |
| #576 | Argen-X | BR:ARGX | $47.46 Billion | €893.60 |
Plantarc Bio Ltd Historical Marketcap From 2021 to 2025
Between 2021 and today, Plantarc Bio Ltd's market cap moved from $6.67 Million to $ 1.96 Million, with a yearly change of -33.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ILA1.96 Million | -29.69% |
| 2024 | ILA2.79 Million | -6.74% |
| 2023 | ILA2.99 Million | -57.45% |
| 2022 | ILA7.02 Million | +5.28% |
| 2021 | ILA6.67 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 6th, 2026 the market cap of Plantarc Bio Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.96 Million USD |
| MoneyControl | $1.96 Million USD |
| MarketWatch | $1.96 Million USD |
| marketcap.company | $1.96 Million USD |
| Reuters | $1.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Plantarc Bio Ltd
PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.